Clinical trials of human lung surfactant from amniotic fluids in neonatal respiratory distress syndrome

О. А. Rosenberg; Rosenberg О. А.; A. G. Antonov; Antonov A. G.; N. N. Volodin; Volodin N. N.; V. A. Volchkov; Volchkov V. A.; O. B. Milenin; Milenin O. B.; I. I. Rumina; Rumina I. I.; Ed. K. Tsybulkili; Tsybulkili Ed. K.

doi:10.17816/JOWD101367

Clinical trials of human lung surfactant from amniotic fluids in neonatal respiratory distress syndrome

Authors: Rosenberg О.А.¹^,2^,3^,4^,5, Antonov A.G.¹^,2^,3^,4^,5, Volodin N.N.¹^,2^,3^,4^,5, Volchkov V.A.¹^,2^,3^,4^,5, Milenin O.B.¹^,2^,3^,4^,5, Rumina I.I.¹^,2^,3^,4^,5, Tsybulkili E.K.¹^,2^,3^,4^,5
Affiliations:
1. CRIRR
2. CROGP RAMS
3. RASPM
4. RAPDE, MIPeds and Surg.
5. SPPMA
Issue: Vol 48, No 5S (1999)
Pages: 130-130
Section: Articles
URL: https://journals.rcsi.science/jowd/article/view/101367
DOI: https://doi.org/10.17816/JOWD101367
ID: 101367

Cite item

Full Text

Abstract
Full Text
About the authors
References
Statistics

Abstract

Objective: Estimation of the efficiency, tolerance and safety of «Surfactant-HL» (ST-HL) (CRIRR, St. Petersburg, Russia) for treatment of neonatal respiratory distress syndrome (NRDS) was performed in 5 Russian neonatal departments in Moscow and St. Petersburg.

Keywords

lung surfactant, amniotic fluids, neonatal respiratory distress syndrome, clinical trials